These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32614498)

  • 1. Where are oral and dental adverse drug effects in product information?
    Teoh L; Stewart K; Moses G
    Int J Pharm Pract; 2020 Dec; 28(6):591-598. PubMed ID: 32614498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained Decline of Direct General Practitioner Reporting of Adverse Drug Reactions in Australia and Paucity in Details of Australian Reports in Safety Advisories.
    Boyd IW; McEwen J
    Drug Saf; 2023 Jul; 46(7):703-710. PubMed ID: 37266905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing the oral side-effects of medications used to treat multiple sclerosis.
    Cockburn N; Pateman K; Taing MW; Pradhan A; Ford PJ
    Aust Dent J; 2017 Sep; 62(3):331-336. PubMed ID: 28276076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug and device reactions in the oral cavity: surveillance and reporting.
    Zavras AI; Rosenberg GE; Danielson JD; Cartsos VM
    J Am Dent Assoc; 2013 Sep; 144(9):1014-21. PubMed ID: 23989840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refill adherence and self-reported adverse drug reactions and sub-therapeutic effects: a population-based study.
    Hedna K; Hägg S; Andersson Sundell K; Petzold M; Hakkarainen KM
    Pharmacoepidemiol Drug Saf; 2013 Dec; 22(12):1317-25. PubMed ID: 24127242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of psychotropic drugs and associated dental diseases.
    Fratto G; Manzon L
    Int J Psychiatry Med; 2014; 48(3):185-97. PubMed ID: 25492713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk management strategies for reducing oral adverse drug events.
    Spolarich AE
    J Evid Based Dent Pract; 2014 Jun; 14 Suppl():87-94.e1. PubMed ID: 24929593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
    Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
    Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reaction labelling for atomoxetine, methylphenidate and modafinil: comparison of product information for oral formulations in Australia, Denmark and the United States.
    Aagaard L; Hansen EH
    Curr Drug Saf; 2013 Jul; 8(3):162-8. PubMed ID: 23914751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric pharmacovigilance in an institute of national importance: Journey has just begun.
    Sharma PK; Misra AK; Gupta N; Khera D; Gupta A; Khera P
    Indian J Pharmacol; 2017; 49(5):390-395. PubMed ID: 29515280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-Induced Oral Complications.
    Ikeda K
    Atlas Oral Maxillofac Surg Clin North Am; 2017 Sep; 25(2):127-132. PubMed ID: 28778302
    [No Abstract]   [Full Text] [Related]  

  • 13. ADVERSE DRUG REACTIONS IN THE ORAL CAVITY.
    Boras VV; Andabak-Rogulj A; Brailo V; Šimunković SK; Gabrić D; Vrdoljak DV
    Acta Clin Croat; 2015 Jun; 54(2):208-15. PubMed ID: 26415318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting Database.
    Castillon G; Salvo F; Moride Y
    Drug Saf; 2019 Jan; 42(1):27-34. PubMed ID: 30121742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review and guide to drug-associated oral adverse effects-Dental, salivary and neurosensory reactions. Part 1.
    Teoh L; Moses G; McCullough MJ
    J Oral Pathol Med; 2019 Aug; 48(7):626-636. PubMed ID: 31192500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug reactions experience in a teaching hospital in Jordan.
    Alsbou M; Alzubiedi S; Alzobi H; Samhadanah NA; Alsaraireh Y; Alrawashdeh O; Aqel A; Al-Salem K
    Int J Clin Pharm; 2015 Dec; 37(6):1188-93. PubMed ID: 26286340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reactions: classification, susceptibility and reporting.
    Kaufman G
    Nurs Stand; 2016 Aug; 30(50):53-63. PubMed ID: 27507394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug reactions: oral and dental manifestations and complications.
    Schifter M
    Ann R Australas Coll Dent Surg; 2012 Apr; 21():91-3. PubMed ID: 24783838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral health impacts of medications used to treat mental illness.
    Cockburn N; Pradhan A; Taing MW; Kisely S; Ford PJ
    J Affect Disord; 2017 Dec; 223():184-193. PubMed ID: 28759866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the black triangle scheme and its online educational campaign on the quantity and quality of adverse drug event reporting in Australia: a time series analysis.
    Li R; Curtis K; Zaidi STR; Van C; Castelino R
    Expert Opin Drug Saf; 2020 Jun; 19(6):747-753. PubMed ID: 32207361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.